NEW YORK, Feb 6 – Informax's business strategy entails looking beyond off-the-shelf sales of its software toward developing hands-on collaborations, such as the partnership the company forged with Axcell Biosciences, Informax CEO Alex Titomirov said Tuesday.

“We’d like to have collaborations and technologies that map [bioinformatics] onto development,” Titomirov told GenomeWeb following a media seminar in New York.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Science speaks with the University of Michigan's Jedidiah Carlson, who has tracked population genetic discussions at white nationalist sites.

Gene therapies could qualify for a faster US Food and Drug Administration approval process, according to Stat News.

NPR reports that the US House of Representatives has passed a bill to enable terminally ill patients access to experimental drugs.

In Genome Research this week: inversion variants mapped in human, non-human primate genomes; transcriptome profiling of maize, sorghum; and more.